New article here in Spanish, by the Fundació Institut Català de Farmacologia, Hospital Universitari Vall d’Hebron.
https://www.icf.uab.cat/assets/pdf/productes/bg/es/bg312.18e.pdf
Quick translation of the conclusion to English:
Recent data indicate that antidepressants, inhibitors of 5α-reductase (finasteride, dutasteride) and isotretinoin may cause persistent effects on sexuality, which may last for months or years after stopping treatment: decreased desire, anesthesia genital pain, genital pain, erectile dysfunction, inhibition of lubrication, ejaculation problems, anorgasmia.
Before starting a treatment with any of these drugs, it is advisable to inform the patient about it. At the same time, we must be aware of the possible role of pharmacological treatment in patients with new-onset sexuality problems.